Overview

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG11001 )

Status:
RECRUITING

Trial end date:
2026-12-30

Target enrollment:

Participant gender:

Summary

A Clinical Study to Investigate the Safety, Efficacy, and Cellular Metabolism of CT1190B CAR-T Cell therapy, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma.

Phase:

PHASE1

Details

Lead Sponsor:

Tongji Hospital

Treatments:

Immunotherapy, Adoptive